HB 672 Maryland House of Delegates · 2026 Regular Session

Public Health - Maryland Pediatric Cancer Fund - Entities Eligible for Grants

HB 672 amends the Maryland Pediatric Cancer Fund to specify that only nonprofit hospitals, educational institutions, and other nonprofit organizations may receive grants for pediatric cancer research, removing previous eligibility for physicians, laboratories, and individuals. The bill requires grant funds to be used exclusively for direct research costs, prohibiting use for administrative overhead or community-based services. It also mandates annual reporting to the General Assembly on fund administration, promotional efforts, and detailed fund usage.

Issues: ✓ Healthcare

Bill status signed all 5 stages cleared

Introduction

Feb 2026

Committee Review

Apr 2026

House of Delegates Passage

Apr 2026

Senate Passage

Apr 2026

Signed into Law

Apr 2026

Introduced Feb 2, 2026 Signed Apr 28, 2026

Maddy AI version diff · 1 comparison

What changed between versions

First - Public Health - Maryland Pediatric Cancer Fund - Entities Eligible for Grants → Third - Public Health - Maryland Pediatric Cancer Fund - Entities Eligible for Grants · 3 edits

MINOR

The bill was amended to include additional sponsors and marked as an emergency measure to take effect immediately upon enactment rather than a future date. The text of the law itself was reorganized and reformatted, but the substantive definitions of the fund, eligible entities, and funding rules remain unchanged.

Scope change

The bill's effective date changed from October 1, 2026, to the date of enactment due to its classification as an emergency measure.

TIMELINE

The bill is now designated as an emergency measure, allowing it to take effect immediately upon passage instead of waiting until October 1, 2026.

TECHNICAL

The list of bill sponsors was expanded to include several additional delegates.

The bill text was reorganized and reformatted, with the definition of 'pediatric cancer research' moved to a different location within the document.

Floor votes · Senate Mar 26, 2026 · House of Delegates Feb 20, 2026

How they voted

48–0

Passed · 1 other

Total votes 49

Mar 26, 2026

D Democratic36

35 Yea 1

97% Yea

R Republican13

13 Yea

100% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 28, 2026

Signed into law

Approved by the Governor - Chapter 220

executive

Apr 13, 2026

Lower · Passed

Returned Passed

lower

Apr 13, 2026

Upper · Passed

Third Reading Passed

upper

Apr 10, 2026

Upper · Passed

Favorable Adopted

upper

Apr 10, 2026

Upper · Passed

Favorable Report by Finance

upper

Mar 26, 2026

Senate · Passed

Senate Vote: pass (48-0-1)

senate

Feb 27, 2026

Committee

Referred Finance

upper

Feb 26, 2026

Lower · Passed

Third Reading Passed

lower

Feb 24, 2026

Lower · Passed

Favorable with Amendments {

lower

Feb 23, 2026

Lower · Passed

Favorable with Amendments Report by Health

lower

Feb 20, 2026

House Of Delegates · Passed

House of Delegates Vote: pass (136-1-5)

house of delegates

Feb 2, 2026

Committee

First Reading Health

lower

17 primary · 0 co-sponsors